Clinical Trials – Where are we Headed with COVID-19 Trials?

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Covid 19 Clinical Trials Market Overview

The greatest number of COVID-19 clinical trials were in Phase II. Q2 2020 is still the time period that had the highest number of trials since the beginning of the COVID-19 pandemic. Clinical trials for COVID-19 vaccines have increased over time since the beginning of the pandemic. Although the total number of vaccines for COVID-19 clinical trials have increased, there were far fewer vaccine trials in Q1 2022 compared to Q1 2021.

Which are the key regions in the COVID-19 clinical trials market?

The key regions in the COVID-19 clinical trials market are Asia -Pacific, North America, Europe, Middle East & Africa, and South & Central America. Asia-Pacific has the most Phase I, Phase II, and Phase IV clinical trials, while the Middle East and Africa has the most Phase III clinical trials.

COVID-19 clinical trials market, by regions

COVID-19 clinical trials market, by regions

For more regional insights, download a free report sample

Which are the key countries in the COVID-19 clinical trials market?

The key countries in the COVID-19 clinical trials market are the US, India, the UK, Brazil, and China. The US greatly outnumbered all other countries in the number of COVID-19 clinical trial sites.

COVID-19 clinical trials market, by countries

COVID-19 clinical trials market, by countries

For more country insights, download a free report sample

Which are the key industry sponsors in the COVID-19 clinical trials market?

The key industry sponsors in the COVID-19 clinical trials market are Sorrento Therapeutics, Elli Lilly, Novartis, Pfizer, Hamad Medical, Gilead Sciences, Regeneron Pharmaceuticals, Atea Pharmaceuticals, and AstraZeneca. The top industry sponsor for COVID-19 therapeutic clinical trials was Sorrento Therapeutics, compared to the number of trials reported in 2021.

COVID-19 clinical trials market, by industry sponsor

COVID-19 clinical trials market, by industry sponsor

To know more about industry sponsors, download a free report sample

Which are the key non-industry sponsors in the COVID-19 clinical trials market?

The key non-industry sponsors in the COVID-19 clinical trials market are Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Mashhad University of Medical Sciences, Assistance Publique – Hopitaux De Paris, Tabriz University of Medical Sciences, Mazandaran University of Medical Sciences, and Isfahan University of Medical Sciences.

COVID-19 clinical trials market, by non-industry sponsor

COVID-19 clinical trials market, by non-industry sponsor

To know more about non-industry sponsors, download a free report sample

Market report overview

Key regions Asia-Pacific, North America, Europe, Middle East & Africa, and South & Central America
Key countries The US, India, the UK, Brazil, and China
Key industry sponsors Sorrento Therapeutics, Elli Lilly, Novartis, Pfizer, Hamad Medical, Gilead Sciences, Regeneron Pharmaceuticals, Atea Pharmaceuticals, and AstraZeneca
Key non-industry sponsors Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Mashhad University of Medical Sciences, Assistance Publique – Hopitaux De Paris, Tabriz University of Medical Sciences, Mazandaran University of Medical Sciences, and Isfahan University of Medical Sciences

Scope

  • The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included clinical trials, which were captured in the database as of March 30, 2022. The trials were analyzed and segmented by all COVID-19 trials, trials using vaccines, trials using therapeutics, and all trials impacted due to the pandemic. An analysis was also completed on COVID-19 testing and vaccination data.

Reasons to Buy

  • Trends of COVID-19 trials by phase, sponsor type and status
  • Geographical distribution of COVID-19 trials
  • Comparison of COVID-19 trials by vaccines versus therapeutics
  • Impact of COVID-19 of clinical trials
  • COVID-19 testing and vaccination data

Table of Contents

Tables and Figures

• List of Tables

• List of Figures

Executive Summary

Introduction

Analysis of COVID-19 Clinical Trials

COVID-19 Clinical Trials for Vaccines

COVID-19 Clinical Trials for Therapeutics

COVID-19 Testing and Vaccination Data

Impact of COVID-19 on Clinical Trials

Key Findings

Appendix

Table

List of Tables

Table 1: Top Countries in COVID-19 Key Stats

Figures

List of Figures

Figure 1: Impact of COVID-19

Figure 2: Top Countries in COVID-19 Key Stats

Figures 3 & 4: Over 2,000 Vaccines and Therapeutics Are in Development

Figure 5: Number of COVID-19 Clinical Trials by Start Date, by Month

Figure 6: Number of COVID-19 Clinical Trials, by Multinational vs. Single Country

Figure 7: Single Country COVID-19 Clinical Trials, by Region & Phase

Figure 8: Multinational Country COVID-19 Clinical Trials, by Region & Phase

Figure 9: COVID-19 Clinical Trial Sites, by Region

Figures 10 & 11: COVID-19 Clinical Trial Sites, by Country & State

Figures 12 & 13: Number of COVID-19 Clinical Trials, by Phase & Status

Figure 14: Endpoint Status for Completed COVID-19 Clinical Trials

Figure 15: Top Reasons for Terminated Trials, by Phase

Figure 16: Top Reason for Terminated Trials, by Sponsor Type

Figure 17: Long COVID-19 Clinical Trials, by Trial Start Date

Figures 18 & 19: Average Completed Trial Duration for Viral Infections in General vs. COVID-19, by Phase

Figure 20: COVID-19 Clinical Trials by Vaccine, by Trial Start Date

Figures 21 & 22: Vaccine COVID-19 Clinical Trials, by Phase & Status

Figure 23: Vaccine COVID-19 Clinical Trials, by Sponsor Type

Figure 24: Top Industry Sponsors for COVID-19 Vaccine Clinical Trials

Figure 25: Top Non-Industry Sponsors for COVID-19 Vaccine Clinical Trials

Figure 26: Upcoming Filings and Regulatory Approvals for COVID-19 Vaccines

Figure 27: COVID-19 Therapeutic Clinical Trials, by Trial Start Date

Figures 28 & 29: Therapeutic COVID-19 Clinical Trials, by Phase & Status

Figure 30: Therapeutic COVID-19 Clinical Trials, by Sponsor Type

Figure 31: Top Industry Sponsors for COVID-19 Therapeutic Clinical Trials

Figure 32: Top Non-Industry Sponsors for COVID-19 Therapeutic Clinical Trials

Figure 33: Upcoming 2022 Filings and Regulatory Approvals for Therapeutic COVID-19 Drugs

Figure 34: Cumulative Number of COVID-19 Tests, by Country

Figure 35: COVID-19 Tests Per Thousand People, by Country

Figures 36 & 37: Cumulative Number of Fully Vaccinated People per 1M & Number of Vaccinations by Month per 1M, by Country

Figure 38: Fully Vaccinated Population Rate, by Country

Figures 39 & 40: Percent of Population Received One Dose & Percent of Population Received Second Dose, by Country

Figure 41: US COVID-19 Vaccination Administration by Vaccine Type vs. Number of People Fully Vaccinated per 1M

Figure 42: Percent of People in the US Who Received Booster Shoes, by Primary Booster Type

Figure 43: Clinical Trials Disrupted Due to COVID-19

Figures 44 & 45: Disrupted Clinical Trials, by Reason

Figure 46: Disrupted Clinical Trials, by Therapy Area

Figure 47: Disrupted Clinical Trials Relative to Ongoing and Planned Trials, by Therapy Area

Figures 48 & 49: Disrupted Clinical Trials Activities, by Region & Country

Figure 50: Disrupted Clinical Trials, by Top Sponsors

Figure 51: Resumed Clinical Trials After Being Disrupted Due to COVID-19

Figure 52: Percent of Decentralized Clinical Trials, By Start Year

Figure 53: Virtual Components Used In Decentralized Clinical Trials

Frequently asked questions

Clinical Trials – Where are we Headed with COVID-19 Trials? thematic reports
Currency USD
$695

Can be used by individual purchaser only

$1,390

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Clinical Trials – Where are we Headed with COVID-19 Trials? was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Clinical Trials – Where are we Headed with COVID-19 Trials? in real time.

  • Access a live Clinical Trials – Where are we Headed with COVID-19 Trials? dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.